Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
Nature Medicine|July 9, 2009
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primatesTim A Weaver, Ali H Charafeddine, Avinash Agarwal, et al.
Transplantation|August 22, 2009
Dynamics of human regulatory T cells in lung lavages of lung transplant recipientsDavid C Neujahr, Adriana C Cardona, Onome Ulukpo, et al.
Frontiers in Medicine|November 23, 2017
Expression of Mitochondrial-Encoded Genes in Blood Differentiate Acute Renal Allograft RejectionSilke Roedder, Tara Sigdel, Szu-Chuan Hsieh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Functionally significant renal allograft rejection is defined by transcriptional criteriaSteven C Hoffmann, Douglas A Hale, David E Kleiner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 4, 2018
De novo belatacept in clinical vascularized composite allotransplantationLinda C Cendales, David S Ruch, Adela R Cardones, et al.
Transplantation|July 17, 2003
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H)Allan D Kirk, Douglas A Hale, Roslyn B Mannon, et al.
Blood Advances|January 4, 2018
Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primatesJean Kwun, Christopher Burghuber, Miriam Manook, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 21, 2019
Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant studyMichael S Mulvihill, Kannan P Samy, Qimeng A Gao, et al.
Transplantation|November 10, 2005
Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualinAllan D Kirk, Roslyn B Mannon, David E Kleiner, et al.
Transplantation|October 24, 2002
Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injurySteven C Hoffmann, Robert L Kampen, Shashi Amur, et al.
Pageof 22